SLC5A2 and Ventricular arrhythmia: Although SGLT2 inhibitor use was associated with a lower risk of these events, this result was not statistically significant (HR 0.94 [95% CI 0.88‐1.00]; log‐rank P value = 0.628 [Table 3]), indicating that they had no effect on ventricular arrhythmias.